accurate, low cost and portable technology to easily detect COVID-19 in just a few minutes. We now have a highly versatile technology which we believe will be widely adopted as a complete health monitoring system to further decentralize healthcare and enable remote care and telehealth.”
This research was backed by the US National Institutes of Health’s Rapid Acceleration of Diagnostics (RADx SM) program and was partially or entirely financed by Federal funds from the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Department of Health and Human Services, as part of the Contract #75N92021C00025. Additionally, it also received funds from the Korea Ministries of Science, Small and Medium-Sized Enterprises and Startups, and Health and Welfare, as well as the Seoul Metropolitan Government.
